Concepedia

Publication | Open Access

AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney

109

Citations

20

References

2012

Year

Abstract

In patients with mRCC, AMG 386 plus sorafenib was tolerable but did not significantly improve PFS compared with placebo plus sorafenib.

References

YearCitations

Page 1